Thomas received his PhD in Bioengineering from Clemson University (Clemson, SC, USA) in 2013. His research was focused on developing theranostic nanomedicines for the treatment of cancer. Following his doctorate, he joined the BioNanomaterials group at the Adolphe Merkle Institute (Fribourg, Switzerland) as a postdoctoral researcher. There he studied the fundamental structure-function interactions of nanoparticles with biological system.
Currently, he is a Marie Sklodowska-Curie COFUND MINDED Researcher at the Italian Institute of Technology where he works on engineering cells to transport particles across the blood-brain barrier, in particular to treat neurodevelopmental disorders. He is interested in how particle drug delivery vehicles can be used to transport therapeutics across biological barriers, and he is studying this in both microfluidic in vitro models and in vivo.